Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan Graduate Institute of Clinical Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Department of Anesthesiology, Taipei Medical University Hospital, Taipei, Taiwan Department of Anesthesiology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
Ann Rheum Dis. 2014 Sep;73(9):1646-51. doi: 10.1136/annrheumdis-2012-202758. Epub 2013 Jun 5.
To investigate the postoperative adverse outcomes among surgical patients with preoperative systemic lupus erythematosus (SLE) in a nationwide population-based study.
We used Taiwan's National Health Insurance Research Database to identify 4321 surgical inpatients with SLE and 17 284 sex- and age-matched controls receiving major surgery. Sociodemographic characteristics, preoperative comorbidities, postoperative 30-day in-hospital major complications and mortality were analysed among surgical patients with and without SLE.
Surgical patients with SLE had a higher prevalence of preoperative coexisting medical conditions and postoperative major complications. The OR of 30-day postoperative mortality for surgical patients with SLE was 1.71 (95% CI 1.09 to 2.67) after adjustment. Surgical patients who had received more recent (within 6 months) preoperative SLE-related inpatient care had higher risks of 30-day postoperative acute renal failure (OR=7.23, 95% CI 4.52 to 11.6), pneumonia (OR=2.60, 95% CI 1.82 to 3.72), pulmonary embolism (OR=4.86, 95% CI 1.20 to 19.7), septicaemia (OR=3.43, 95% CI 2.48 to 4.74), stroke (OR=2.01, 95% CI 1.38 to 2.92), overall complications (OR=2.30, 95% CI 1.89 to 2.80) and 30-day postoperative mortality (OR=2.39, 95% CI 1.28 to 4.45) than surgical patients without SLE. SLE-related preoperative steroid injections showed a dose-dependent relationship with postoperative complications and mortality.
SLE significantly increased the risks of surgical patients for overall major complications and mortality after major surgery. Our findings demonstrated the need for integrated care and revised protocols for perioperative management to improve outcomes for surgical patients with SLE.
在一项全国性基于人群的研究中,调查接受手术的系统性红斑狼疮(SLE)患者的术后不良结局。
我们使用台湾全民健康保险研究数据库,确定了 4321 名患有 SLE 的住院手术患者和 17284 名性别和年龄匹配的接受大手术的对照组。分析了 SLE 患者和非 SLE 患者的人口统计学特征、术前合并症、术后 30 天院内主要并发症和死亡率。
SLE 手术患者术前共存疾病和术后主要并发症的患病率较高。调整后 SLE 手术患者 30 天术后死亡率的 OR 为 1.71(95%CI 1.09 至 2.67)。最近(6 个月内)接受过 SLE 相关住院治疗的手术患者发生 30 天术后急性肾衰竭的风险较高(OR=7.23,95%CI 4.52 至 11.6)、肺炎(OR=2.60,95%CI 1.82 至 3.72)、肺栓塞(OR=4.86,95%CI 1.20 至 19.7)、败血症(OR=3.43,95%CI 2.48 至 4.74)、中风(OR=2.01,95%CI 1.38 至 2.92)、总体并发症(OR=2.30,95%CI 1.89 至 2.80)和 30 天术后死亡率(OR=2.39,95%CI 1.28 至 4.45)均高于非 SLE 手术患者。SLE 相关术前皮质类固醇注射与术后并发症和死亡率呈剂量依赖性关系。
SLE 显著增加了手术患者接受大手术后总体主要并发症和死亡率的风险。我们的研究结果表明,需要对围手术期管理进行综合护理和修订方案,以改善 SLE 手术患者的结局。